Fundz

MapLight Therapeutics raised $372.5M in Series D funding led by Forbion and Life Sciences at Goldman Sachs Alternatives to advance ML-007C-MA for schizophrenia and Alzheimer’s disease.

PUBLIC · MPLTJul 28, 2025

Amount Raised

$373 Million

Round Type

Series D

Redwood CityBiotechnologyHealth CareTherapeutics

Investors

Avego Bioscience Capital5AM VenturesNovo HoldingsLife Sciences At Goldman Sachs AlternativesSanofiBlue Owl Healthcare OpportunitiesT. Rowe Price Investment ManagementForbion

Description

MapLight Therapeutics, a Redwood City, CA-based clinical-stage biopharmaceutical company, raised $372.5M in Series D financing. The round was led by Forbion and Life Sciences at Goldman Sachs Alternatives, with participation from new investors, including Sanofi and T. Rowe Price. The company intends to use the funds to advance ML-007C-MA through ongoing Phase 2 trials

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as MapLight Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • iRegene Therapeutics raised an undisclosed amount (Series B) on September 9, 2025.
  • Alchemab Therapeutics raised an undisclosed amount (Series A) on September 9, 2025.
  • Integra Therapeutics raised $13M (Funding Round) on September 8, 2025.
  • NRG Therapeutics raised $67M (Funding Round) on September 8, 2025.
  • MRM Health raised $64M (Series B) on September 4, 2025.
  • TNF Pharmaceuticals raised $7M on September 2, 2025.

Who to call at MapLight Therapeutics, and when

A new round usually means MapLight Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MapLight Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MapLight Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MapLight Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MapLight Therapeutics

Location

800 Chesapeake Drive

Redwood City, California, United States

About

Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MapLight Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts17 people are listed at MapLight Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MapLight Therapeutics's next move

See what Strategic adds

MapLight Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.